SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users
8 references·16 citing·34 second hop
Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users (2000)Psychobiological problems in heavy 'ecsta…(±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Studies in Animals (2000)(±)3,4-Methylenedioxymethamph…Memory deficits associated with recreational use of "ecstasy" (MDMA) (1999)Memory deficits associated wi…Positron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beings (1998)Positron emission tomographic…Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance (1998)Ecstasy (MDMA) effects upon m…Mood and cognitive effects of ± 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’): week‐end ‘high’ followed by mid‐week low (1997)Mood and cognitive effects of…Serotonin Neurotoxicity after (±)3,4-Methylenedioxymethamphetamine (MDMA; “Ecstasy”): A Controlled Study in Humans (1994)Serotonin Neurotoxicity after…3,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”): pharmacology and toxicology in animals and humans (1994)3,4‐Methylenedioxymethampheta…Recreational MDMA use in Sydney: a profile of ‘Ecstasy’ users and their experiences with the drug (1992)Recreational MDMA use in Sydn…Human psychobiology of MDMA or ‘Ecstasy’: an overview of 25 years of empirical research (2013)Human psychobiology of MDMA o…The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview (2006)The confounding problem of po…Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage? (2006)Neurotoxicity of methylenedio…Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective (2006)Mood, cognition and serotonin…Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy (2005)Chronic tolerance to recreati…Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: A WWW study (2004)Increased intensity of Ecstas…Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function (2004)Acute and long-term effects o…Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users (2003)Mood, cognition and serotonin…Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms (2003)Methylenedioxymethamphetamine…Altered states: the clinical effects of Ecstasy (2003)Altered states: the clinical …The health effects of ecstasy: a literature review (2002)The health effects of ecstasy…Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users (2002)Neuropsychological evidence o…Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users (2002)Ecstasy/MDMA attributed probl…Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies (2001)Which neuroreceptors mediate …Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems (2001)Recreational ecstasy/MDMA and…Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence? (2001)Ecstasy (MDMA): are the psych…An inventory for assessing different kinds of hostility. (1957)Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior (1983)Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. (1987)Cognitive performance in (±) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study (1999)Impaired cognitive performance in drug free users of recreational ecstasy (MDMA) (2000)Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity (2002)Differences Between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens. Identification of a New Therapeutic Class: Entactogens (1986)3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. (1987)Recreational Use of “Ecstasy” (MDMA) Is Associated with Elevated Impulsivity (1998)Subjective Reports of the Effects of MDMA in a Clinical Setting (1986)Ecstasy (MDMA): a review of its possible persistent psychological effects (2000)Gender differences in the subjective effects of MDMA (2001)Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research (2001)Development of a more reliable version of the Matching Familiar Figures Test. (1978)The development and validation of a test battery for detecting and monitoring everyday memory problems (1989)Modeling Sources of Self-report Bias in a Survey of Drug Use Epidemiology (2004)The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) (2003)Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[11C]DASB and structural brain imaging study (2010)Clinical applications of hallucinogens: A review. (2016)Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents (1984)Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action (1998)The Standardized Psychometric Assessment of Altered States of Consciousness (ASCs) in Humans (1998)The Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level–Dependent Resting State Functional Connectivity (2014)The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals (2015)MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms? (2018)Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain. (1987)3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings (2006)Molecular and Cellular Mechanisms of Ecstasy-Induced Neurotoxicity: An Overview (2009)The use of analogue scales in rating subjective feelings (1974)The handbook of psychotherapy and behaviour change (1979)Rivermead Behavioural Memory Test (1990)Cognitive performance in recreational users of MDMA or 'ecstasy': evidence for memory deficits (1998)Cognitive performance amongst recreational users of "ecstasy" (2000)Cardiovascular and Neuroendocrine Effects and Pharmacokinetics of 3,4-Methylenedioxymethamphetamine in Humans (1999)
this work references cited by second hop

References

  • 1998Positron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beings658 cited
  • 1992Recreational MDMA use in Sydney: a profile of ‘Ecstasy’ users and their experiences with the drug413 cited
  • 1998Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance341 cited
  • 1994Serotonin Neurotoxicity after (±)3,4-Methylenedioxymethamphetamine (MDMA; “Ecstasy”): A Controlled Study in Humans333 cited
  • 2000(±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Studies in Animals292 cited
  • 19943,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”): pharmacology and toxicology in animals and humans289 cited
  • 1997Mood and cognitive effects of ± 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’): week‐end ‘high’ followed by mid‐week low283 cited
  • 1999Memory deficits associated with recreational use of "ecstasy" (MDMA)281 cited

Cited by

  • 2005Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy238 cited
  • 2001Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies236 cited
  • 2001Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?227 cited
  • 2001Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems210 cited
  • 2003

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms
199 cited
  • 2003Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users190 cited
  • 2003Altered states: the clinical effects of Ecstasy190 cited
  • 2006Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?189 cited
  • 2013Human psychobiology of MDMA or ‘Ecstasy’: an overview of 25 years of empirical research185 cited
  • 2002Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users181 cited
  • 2006The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview179 cited
  • 2004Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: A WWW study166 cited
  • 2002Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users161 cited
  • 2006Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective158 cited
  • 2004Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function153 cited
  • 2002The health effects of ecstasy: a literature review153 cited